Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 75-79

  Fietkau, R ^a   Riepl, M ^a   Kettner, H ^b   Hinke, A ^c   Sauer, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Bristol Arzneimittel GmbH   (Germany)

^c Wissenschaftlicher Service Pharma   (Germany)

Author keywords

head and neck cancer; megestrol acetate; nutritional status; quality of life; radio(chemo)therapy

Indexed keywords

MEGESTROL ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTHROPOMETRY; APPETITE STIMULANTS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; NUTRITIONAL STATUS; QUALITY OF LIFE; SKINFOLD THICKNESS; WEIGHT LOSS;

EID: 0031030775     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00309-7     Document Type: Article

References (29)

1. 1. Arnold C, Richter MP. The effect of oral nutritional supplements on head and neck cancer. Int J Radiat Oncol Biol Phys 1989, 16, 1595-1599.
2. 2. Baredes S, Blitzer A. Nutritional considerations in the management of head and neck cancer patients. Otol Clin N Am 1989, 17, 725-730.
3. 3. Thiel HJ, Fietkau R, Sauer R. Malnutrition and the role of nutritional support for radiation therapy patients. Rec Res Cancer Res 1988, 108, 205-222.
4. 4. Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Rec Res Cancer Res 1991, 121, 269-282.
5. 5. Senft M, Fietkau R, Iro H, Sailer D, Sauer R. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life cancer patients. Supp Care Cancer 1993, 1, 272-275.
6. 6. Gregory EJ, Cohen SC, Oines DW, et al. Megestrol acetate therapy for advanced breast cancer. J Clin Oncol 1985, 3, 155-160.
7. 7. Tchekmedyian NS, Tait N, Moody M, et al. High-dose megestrol acetate: a possible treatment for cachexia. JAMA 1987, 257, 1195-1198.
8. 8. Bruera H, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 1990, 66, 1279-1282.
9. 9. Feliu J, Gonzalez-Barn M, Berrocal A, et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. J Clin Oncol 1992, 15, 436-440.
10. 10. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990, 82, 1127-1132.
11. 11. Tchekmedyian NS, Hickman M, Siau J, et al. Megestrol acetate in cancer anorexia and weight loss. Cancer 1992, 69, 1268-1274.
12. 12. Schmoll E, Wilke HJ, Thole R, Preusser P, Wildfang I, Schmoll HJ. Megestrol acetate in cancer cachexia. Semin Oncol 1991, 18 (Suppl.), 32-34.
13. 13. Kornblith AB, Hollis DR, Zuckerman E, et al. Effect of megestrol acetate on quality of life in a dose response trial in women with advanced breast cancer. J Clin Oncol 1993, 11, 2081-2089.
14. 14. Obsoba D, Murray N, Gelmon K, et al. Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy. Oncology (Huntingt.) 1994, 8, 43-49.
15. 15. Tchekmedyian NS, Hickman M, Siau J, et al. Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology 1990, 5, 119-126.
16. 16. Fietkau R, Iro H, Grabenbauer GG, Altendurf-Hofmann A, Sauer R. Simultane radio-Chemotherapie mit cisplatin und 5-fluorouracil bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1991, 167, 693-700.
17. 17. Fietkau R, Weidenbecher M, Spitzer W, Sauer R. Temporary and permanent brachycurie therapy in advanced head and neck cancer - The Erlangen experience. In Sauer R (Hrsg.). Interventional Radiation Therapy: Techniques-Brachytherapy. Berlin, Heidelberg, New York, Springer-Verlag, 1991, 159-169.
18. 18. Wendt TG, Wustrow TPU, Schalhorn A. Ergebnisse der simultanen Radio-Chemotherapie bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1990, 16, 569-579.
19. 19. Fietkau R, Thiel HJ, Iro H, et al. Vergleich von oraler und enteraler Ernährung mittels perkutaner endoskopisch kontrollierter Gastrostomie (PEG) bei Strahlentherapie-Patienten mit Kopf-Hals-Tumoren. Strahlenther Onkol 1989, 165, 844-851.
20. 20. Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F. Quality of life index for patients with cancer. Res Nurs Health 1983, 6, 117-126.
21. 21. Rodda BE, Tsianco MC, Bolognese JA, Kersten MK. Clinical development. In Peace KE (Hrsg.). Biopharmaceutical Statistica for Drug Development. Marcel Dekker, New York, 1988, 273-328.
22. 22. Chencharik JD, Mossman KL. Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 1983, 51, 811-815.
23. 23. Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993, 11, 152-154.
24. 24. Reithmeier M, Hartenstein RC. Megestrol acetate and determination of body composition by bioelectncal impedance analysis in cancer cachexia. Proc Am Soc Clin Oncol 1990, 9, 325 (abstract).
25. 25. Hamburger AW, Parnes H, Gordan GB, et al. Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro. Semin Oncol 1988, 15 (Suppl. 1), 76-78.
26. 26. Aaronson NK. Assessing the quality of life of patients in cancer clinical trial: common problems and common sense solutions. Eur J Cancer 1992, 28A, 1304-1307.
27. 27. Hopwood P. Progress, problems and priorities in quality of life research. Eur J Cancer 1992, 28A, 1748-1752.
28. 28. Ackermann M, Kirchner H, Atzpodien J. Low dose megestrol acetate can abrogate cachexia in advanced tumor patients receiving systemic interferon-alpha and/or interleukin-2 based antincoplastic therapy. Anti-Cancer Drugs 1993, 4, 585-587.
29. 29. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993, 11, 762-767.